Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04651816 · ClinicalTrials.gov registry record · NA
Diabetes Prevention Program Pilot
A NA study of Pre Diabetes, sponsored by Penn State University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04651816 is a NA study of Pre Diabetes that has completed, run by Penn State University. The registered enrollment target is 30 participants, below the 729-participant average among 59 other Pre Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04651816, a NA study of Pre Diabetes, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This initiative, which is a partnership between State College area Penn State Health ambulatory care clinics located off campus in the State College area, has two primary goals: 1) improve the health and quality of life of Penn State Health patients with pre-diabetes and 2) decrease associated health care costs due to type 2 diabetes and its complications. The results from the study may serve as a model for additional chronic disease prevention programs to implement in additional Penn State Health clinics in the future.
Conditions Studied
Interventions
- BEHAVIORAL Financial Incentives
- BEHAVIORAL Motivational Message
- BEHAVIORAL DPP Program
Study Locations (1)
Pennsylvania
- Penn State Health Medical Group -- Park Avenue - State College
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-05-25 |
| Est. Completion | 2023-08-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04651816
The ClinicalTrials.gov registry entry for NCT04651816 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 729-participant average among 59 other Pre Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pre Diabetes appearing as the primary indexed condition, and to 3 interventions - of which Financial Incentives is the first listed.
NCT04651816 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04651816 about?
NCT04651816 is a clinical study titled "Diabetes Prevention Program Pilot". This initiative, which is a partnership between State College area Penn State Health ambulatory care clinics located off campus in the State College area, has two primary goals: 1) improve the health and quality of life of Penn State Health patients with pre-diabetes and 2) decrease associated healt...
What is the current status of trial NCT04651816?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-05-25. Estimated completion is 2023-08-08.
What conditions does trial NCT04651816 study?
This clinical trial studies the following conditions: Pre Diabetes.
What interventions are being tested in trial NCT04651816?
The interventions under investigation include: Financial Incentives (BEHAVIORAL), Motivational Message (BEHAVIORAL), DPP Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04651816?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04651816 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pre Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c
RECRUITING · NA
-
Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals
RECRUITING · NA
-
MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors
RECRUITING · NA
-
Stand Up for Your Health with a Sit-stand Desk
RECRUITING · NA
-
Sisters of Heart (Hermanas de Corazón): A Community Health Worker Initiative for Improving Heart Health in Migrant Farmworker Women
RECRUITING · NA
-
Full Plate Living Nutrition Education Program
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.